Compounded vs. Brand-Name GLP-1: What's the Real Difference?
You've seen both options — Wegovy and Ozempic on one side, compounded semaglutide on the other. Same active ingredient, very different prices. Before you decide, here's a plain-English breakdown of what actually separates them: regulation, quality, cost, and when each one makes sense.
Key takeaways
Brand-name GLP-1s (Wegovy®, Ozempic®, Zepbound®) are FDA-approved and manufactured under strict federal quality controls. Compounded GLP-1s are not FDA-approved and are prepared by state-licensed pharmacies.
Both contain the same active ingredient — semaglutide base or tirzepatide — but compounded formulations may differ in strength, additives, and delivery method.
Brand-name Wegovy® lists at ~$1,349/month at retail. Compounded semaglutide at Ondra Health starts at $113/month on a quarterly plan.
Compounded medications are only legally prepared by state-licensed 503A and 503B pharmacies under a valid prescription from a licensed provider, when a legitimate clinical need exists.
The right choice depends on your budget, insurance status, clinical needs, and comfort with non-FDA-approved medication — a decision best made with a licensed provider.
The core question: same drug, different product?
When people ask whether compounded semaglutide is "the same" as Wegovy or Ozempic, the answer is: partly. The active ingredient — semaglutide base — is the same molecule. It works through the same GLP-1 receptor pathway, produces the same appetite-suppressing effects, and follows the same weekly injection schedule.
What's different is everything around that molecule: how it was made, who reviewed it, how consistent the dosing is, and what else it might contain. Those differences matter — and they explain both the price gap and the regulatory distinction.
What "FDA-approved" actually means
When the FDA approves a drug, it has reviewed clinical trial data confirming the medication is safe and effective for its intended use, and it has inspected the manufacturing facility to verify quality controls, sterility, and consistent dosing. Every batch of Wegovy® or Ozempic® produced by Novo Nordisk must meet those ongoing standards.
What FDA approval covers
Safety and efficacy data from large clinical trials. Manufacturing quality and sterility inspections. Consistent potency and dosing across every batch. Ongoing post-market surveillance for adverse events.
What FDA approval does not guarantee
That the medication will work for every individual patient. That it will be covered by insurance. That side effects won't occur. That it's affordable without insurance coverage.
Compounded medications go through none of this federal review process. That doesn't mean they're automatically unsafe — but it does mean quality assurance falls to state pharmacy boards and the pharmacy's own processes, not federal inspection.
Side-by-side comparison
Compounded medications are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or manufacturing quality. Pricing reflects publicly available 2026 figures.
How compounding pharmacies work — and why they exist
Compounding pharmacies have a long and legitimate history in medicine. They exist to prepare medications for patients who need something a commercial drug can't provide — a different dose strength, a formulation free of a specific allergen, or a combination not available off the shelf.
Under Section 503A of the Federal Food, Drug, and Cosmetic Act, licensed compounding pharmacies may prepare medications based on a valid patient-specific prescription when a licensed provider determines a compounded version is clinically appropriate.
503A pharmacies
Compound medications based on individual patient prescriptions from licensed providers. Subject to state pharmacy board oversight. Cannot produce large batches for general dispensing.
503B outsourcing facilities
Registered with the FDA and subject to stricter Current Good Manufacturing Practice (CGMP) standards. Can produce larger batches. Subject to FDA inspections in addition to state oversight.
All of Ondra Health's pharmacy partners are state-licensed 503A or 503B facilities. Every prescription is issued by an independent, licensed healthcare provider based on individual clinical evaluation — not automated approval.
The formulation differences that matter
Beyond FDA approval status, there are practical formulation differences worth knowing about before you start.
Pen vs. vial
Brand-name GLP-1s come in pre-filled auto-injector pens — click, inject, done. Most compounded versions come as multi-dose vials that require drawing the medication into a syringe yourself. For many patients this is straightforward; for others, the pen is worth the extra cost. Proper injection technique is the same either way.
Additives
Compounded formulations can include supportive ingredients not found in brand-name versions. Common additives include Vitamin B12 (for energy support and potential GI tolerance), Glycine (an amino acid sometimes included for tolerability), and Vitamin B6. Some patients prefer additive-free formulations. The additive profile depends on your pharmacy — all options are listed clearly before you choose.
Semaglutide base vs. salt forms
The FDA has clarified that compounded semaglutide must use semaglutide base — the same active form found in Wegovy and Ozempic. Salt forms such as semaglutide sodium or semaglutide acetate are not FDA-recognized as equivalent and should not be used. Always confirm your pharmacy uses the base form.
The safety question answered honestly
The honest answer is: it depends on the pharmacy. Compounding done well by a state-licensed, quality-controlled pharmacy is meaningfully different from compounding done poorly — and both exist in the market.
The FDA has received adverse event reports linked to compounded GLP-1 products, many involving dosing errors from multi-dose vials when patients self-administered incorrect amounts. These incidents were largely concentrated among products from unverified or lower-quality sources — not from well-run licensed pharmacies.
What reduces risk with compounded GLP-1s
Using a state-licensed 503A or 503B pharmacy with verifiable credentials. Obtaining a valid prescription from a licensed provider who conducts a real clinical evaluation. Confirming the pharmacy uses semaglutide base (not a salt form). Following dosing instructions precisely and communicating with your provider.
Red flags to avoid entirely
Any source selling GLP-1 medications without requiring a prescription. "Research-grade" or "peptide" semaglutide sold online — these are illegal and unregulated. Providers who approve prescriptions without any clinical review. Pharmacies that cannot confirm state licensure or provide documentation of their active ingredient sourcing.
When brand-name makes more sense
You have insurance that partially covers it
If your commercial plan covers Wegovy or Zepbound — even partially — the manufacturer savings card can bring costs to as low as $25/month. That's the best deal in this space if you qualify.
You strongly prefer the auto-injector pen
Pre-filled pens remove the need to draw medication from a vial. For patients with needle anxiety or dexterity concerns, this is a legitimate clinical reason to prefer brand-name delivery.
You want FDA-reviewed manufacturing assurance
For some patients, FDA oversight of every batch is a non-negotiable comfort. That's a reasonable position — brand-name medications carry a level of manufacturing certainty that compounded alternatives don't.
When compounded makes more sense
Cost is the primary barrier
For patients without insurance coverage for GLP-1s — which describes the majority of people seeking weight management treatment — brand-name pricing at $1,000+/month is simply not sustainable. Compounded alternatives from licensed providers make long-term treatment financially viable.
You need a formulation with specific additives
Some patients benefit from formulations that include B12 for energy support or Glycine for tolerability — combinations not available in brand-name products.
You're working with a licensed provider who conducts real clinical review
At Ondra Health, every patient is reviewed by an independent, board-certified physician before a prescription is issued. The compounded route is only offered when it's clinically appropriate for that individual.
The bottom line
Brand-name and compounded GLP-1s are not the same product — but they share the same active ingredient and work through the same mechanism. The core trade-off is FDA manufacturing assurance and pen delivery (brand-name) versus significantly lower cost and formulation flexibility (compounded).
Neither is the right answer for everyone. For patients who can access brand-name coverage through insurance savings programs, that's often the better path. For the majority of patients paying out of pocket, compounded GLP-1s from licensed providers and pharmacies represent a legitimate, cost-accessible route to the same treatment — when obtained through proper clinical channels.
Whatever you choose: get a real prescription from a real licensed provider, verify your pharmacy's credentials, and never use any source that doesn't require those things.
Frequently asked questions
Is compounded semaglutide the same as Wegovy or Ozempic?
Compounded semaglutide contains the same active ingredient — semaglutide base — as Wegovy and Ozempic, but it is not FDA-approved. It is prepared by a state-licensed 503A or 503B compounding pharmacy under a valid prescription and has not been reviewed by the FDA for safety, effectiveness, or manufacturing quality.
Is compounded GLP-1 medication legal?
Compounded GLP-1 medications are legal when prepared by a state-licensed 503A or 503B pharmacy under a valid prescription from a licensed provider, when a legitimate clinical need exists. All prescribing decisions at Ondra Health are made by independent, licensed healthcare providers.
What additives do compounded GLP-1 formulations include?
Depending on the pharmacy and your provider's assessment, compounded GLP-1 formulations may include supportive additives such as a B12/Glycine blend, Vitamin B6, or Glycine. Some formulations contain no additives. You can review the additive profile for each pharmacy on Ondra Health's treatments page before starting.
Why is compounded semaglutide so much cheaper?
Compounded medications bypass the manufacturer's pricing structure and are prepared directly by compounding pharmacies without the overhead of large-scale pharmaceutical manufacturing, brand marketing, or the cost of the FDA approval process — which is why they can be offered at a fraction of brand-name prices.
What should I look for in a compounding pharmacy?
Look for state-licensed 503A or 503B pharmacies, a requirement for a valid prescription from a licensed provider, transparent documentation of active ingredient sourcing (semaglutide base, not salt forms), and verifiable state licensure. Avoid any source that sells GLP-1 medications without a prescription.
Can I switch from compounded to brand-name, or vice versa?
Yes. Patients switch between compounded and brand-name GLP-1s based on cost, availability, insurance changes, or provider recommendation. Any transition should be discussed with your licensed provider, who will determine the appropriate dosing for the new formulation.
† This article is for educational purposes only and does not constitute medical advice. Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or manufacturing quality. All prescribing decisions are made by independent, licensed healthcare providers. Brand names (Wegovy®, Ozempic®, Zepbound®, Mounjaro®) are referenced for informational purposes only. Ondra Health is not affiliated with Novo Nordisk or Eli Lilly. Always consult a qualified healthcare provider before starting, stopping, or changing any treatment plan.